10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol

[1]  T. H. Nguyen,et al.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.

[2]  Pere Almagro,et al.  Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable , 2017 .

[3]  J. Soriano,et al.  Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. , 2017, Archivos de bronconeumologia.

[4]  J. Soriano,et al.  Overdiagnosis of COPD: precise definitions and proposals for improvement. , 2017, The British journal of general practice : the journal of the Royal College of General Practitioners.

[5]  Bartolomé R. Celli,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. , 2017, Archivos de bronconeumologia.

[6]  Joyce D. Schroeder,et al.  Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. , 2016, European journal of radiology.

[7]  P. Burney,et al.  Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.

[8]  J. Soriano,et al.  Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care , 2015, COPD.

[9]  G. J. Serdá,et al.  Prevalence of chronic obstructive pulmonary disease in the Canary Islands. , 2014 .

[10]  B. Celli,et al.  Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE , 2014, Thorax.

[11]  W. Vollmer,et al.  Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form , 2014, BMC Medical Research Methodology.

[12]  J. Jardim,et al.  Comorbilidades y estado de salud en individuos con y sin EPOC en 5 ciudades de América Latina: Estudio PLATINO , 2013 .

[13]  A. Menezes,et al.  Comorbidities and Health Status in Individuals With and Without COPD in Five Latin American Cities: The PLATINO Study ☆ , 2013 .

[14]  J. Galdiz,et al.  Recommendations of SEPARSpirometryEspirometría , 2013 .

[15]  Grace Parraga,et al.  Computed tomography density histogram analysis to evaluate pulmonary emphysema in ex-smokers. , 2013, Academic radiology.

[16]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[17]  Xavier Badia,et al.  Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations? , 2012, COPD.

[18]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[19]  Ella A. Kazerooni,et al.  CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression , 2012, Nature Medicine.

[20]  Ignasi Serra,et al.  [Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients]. , 2011, Archivos de bronconeumologia.

[21]  D. Donaire-Gonzalez,et al.  Validation of the Yale Physical Activity Survey in Chronic Obstructive Pulmonary Disease Patients , 2011 .

[22]  J. Soriano,et al.  Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007 , 2009, European Respiratory Journal.

[23]  D. Price,et al.  Screening for and early detection of chronic obstructive pulmonary disease , 2009, The Lancet.

[24]  J. Soriano,et al.  Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities , 2009, Thorax.

[25]  M. Miravitlles,et al.  Datos epidemiológicos de EPOC en España , 2007 .

[26]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[27]  G. Viegi,et al.  Coming together: the ATS/ERS consensus on clinical pulmonary function testing , 2005, European Respiratory Journal.

[28]  I. Arostegui,et al.  Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale , 2003, Acta psychiatrica Scandinavica.

[29]  M. Ferrer,et al.  Interpretation of quality of life scores from the St George's Respiratory Questionnaire , 2002, European Respiratory Journal.

[30]  S. Márquez,et al.  Validity and reliability of the Yale Physical Activity Survey in Spanish elderly. , 2001, The Journal of sports medicine and physical fitness.

[31]  F. L. Fernández,et al.  Correlación entre medidas de salud subjetivas y objetivas en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) , 2001 .

[32]  F. L. Fernández,et al.  Salud autopercibida, apoyo social y familiar de los pacientes con enfermedad pulmonar obstructiva crónica , 2001 .

[33]  M. Miravitlles,et al.  Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. , 2001, Chest.

[34]  M. Miravitlles,et al.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.

[35]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[36]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[37]  E. Becoña,et al.  Scores of Spanish Smokers on Fagerström's Tolerance Questionnaire , 1992, Psychological reports.

[38]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[39]  A. Zigmond,et al.  The Hospital Anxiety and Depression Scale , 1983, Acta psychiatrica Scandinavica.

[40]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[41]  G. Walz.  Equations , 2021, Equations and Inequalities.

[42]  J. Soriano,et al.  Combining case-finding methods for COPD in primary care: a large, two-stage design study. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[43]  J. Soriano,et al.  Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. , 2014, The Lancet. Respiratory medicine.

[44]  J. Hankinson,et al.  MULTI-ETHNIC REFERENCE VALUES FOR SPIROMETRY FOR THE 3–95 YEAR AGE RANGE: THE GLOBAL LUNG FUNCTION , 2013 .

[45]  M. V. Lopez Varela,et al.  Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. , 2013, Archivos de bronconeumologia.

[46]  M. C. Rubio,et al.  Ansiedad y EPOC , 2009 .

[47]  M. Rubio,et al.  [Anxiety and COPD]. , 2009, Archivos de bronconeumologia.

[48]  J. Hankinson,et al.  SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 4 in this Series Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005 .

[49]  J O Prochaska,et al.  Stages of change in the modification of problem behaviors. , 1992, Progress in behavior modification.

[50]  G. Borg.  Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.